The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical <i>PSEN1</i> E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort.
第一作者:
Pierre N,Tariot
第一单位:
Banner Alzheimer's Institute, Phoenix, AZ, USA.
作者:
DOI
10.1016/j.trci.2018.02.002
PMID
29955659
发布时间
2024-05-25
基金项目
P30 AG019610/AG/NIA NIH HHS/United States
R01 AG055444/AG/NIA NIH HHS/United States
RF1 AG041705/AG/NIA NIH HHS/United States
UF1 AG046150/AG/NIA NIH HHS/United States
- 浏览37
Alzheimer's & dementia (New York, N. Y.)
2018年4卷
150-160页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



